Daniel Y. Hung

502 total citations
20 papers, 395 citations indexed

About

Daniel Y. Hung is a scholar working on Oncology, Pharmacology and Molecular Biology. According to data from OpenAlex, Daniel Y. Hung has authored 20 papers receiving a total of 395 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 10 papers in Pharmacology and 4 papers in Molecular Biology. Recurrent topics in Daniel Y. Hung's work include Drug Transport and Resistance Mechanisms (11 papers), Pharmacogenetics and Drug Metabolism (7 papers) and Drug-Induced Hepatotoxicity and Protection (4 papers). Daniel Y. Hung is often cited by papers focused on Drug Transport and Resistance Mechanisms (11 papers), Pharmacogenetics and Drug Metabolism (7 papers) and Drug-Induced Hepatotoxicity and Protection (4 papers). Daniel Y. Hung collaborates with scholars based in Australia, Germany and Canada. Daniel Y. Hung's co-authors include Michael S. Roberts, G. Siebert, Michael Weiß, George D. Mellick, Glen E. P. Ropella, C. Anthony Hunt, Paul P. Masci, Yan Li, Yuri G. Anissimov and Michael A. Weiss and has published in prestigious journals such as Hepatology, Environmental Health Perspectives and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Daniel Y. Hung

20 papers receiving 381 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Daniel Y. Hung Australia	13	138	113	110	81	52	20	395
Kirk Bertelsen United States	8	126 0.9×	188 1.7×	53 0.5×	73 0.9×	49 0.9×	11	456
Maxine Taylor United Kingdom	12	83 0.6×	133 1.2×	111 1.0×	44 0.5×	27 0.5×	14	436
Aaron M. Moss United States	7	193 1.4×	117 1.0×	114 1.0×	45 0.6×	44 0.8×	10	453
Dhanashri Kolwankar United States	8	173 1.3×	158 1.4×	70 0.6×	128 1.6×	25 0.5×	8	419
J P Leroux France	7	97 0.7×	218 1.9×	110 1.0×	56 0.7×	59 1.1×	7	435
Grace Yan United States	9	161 1.2×	52 0.5×	98 0.9×	55 0.7×	26 0.5×	10	316
Noriko Masubuchi Japan	13	168 1.2×	142 1.3×	161 1.5×	45 0.6×	27 0.5×	17	450
H Kinoshita Japan	16	254 1.8×	219 1.9×	124 1.1×	61 0.8×	24 0.5×	51	591
B. Kevin Park United Kingdom	13	93 0.7×	157 1.4×	151 1.4×	68 0.8×	48 0.9×	15	485
Eman El‐Khateeb Egypt	11	134 1.0×	133 1.2×	90 0.8×	102 1.3×	48 0.9×	25	378

Countries citing papers authored by Daniel Y. Hung

Since Specialization

Citations

This map shows the geographic impact of Daniel Y. Hung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Y. Hung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Y. Hung more than expected).

Fields of papers citing papers by Daniel Y. Hung

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Y. Hung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Y. Hung. The network helps show where Daniel Y. Hung may publish in the future.

Co-authorship network of co-authors of Daniel Y. Hung

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Y. Hung. A scholar is included among the top collaborators of Daniel Y. Hung based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Y. Hung. Daniel Y. Hung is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tom, Michael R., Ji Li, Aito Ueno, et al.. (2016). Novel CD8+ T-Cell Subsets Demonstrating Plasticity in Patients with Inflammatory Bowel Disease. Inflammatory Bowel Diseases. 22(7). 1596–1608. 32 indexed citations

Weiß, Michael, et al.. (2008). Kinetic analysis of saturable hepatic uptake of digoxin and its inhibition by rifampicin. European Journal of Pharmaceutical Sciences. 34(4-5). 345–350. 11 indexed citations

Hunt, C. Anthony, Glen E. P. Ropella, Yan Li, Daniel Y. Hung, & Michael S. Roberts. (2006). Physiologically Based Synthetic Models of Hepatic Disposition. Journal of Pharmacokinetics and Pharmacodynamics. 33(6). 737–772. 49 indexed citations

Hunt, C. Anthony, Glen E. P. Ropella, Yan Li, Daniel Y. Hung, & Michael S. Roberts. (2006). Physiologically based synthetic models of hepatic disposition - eScholarship. 33(6). 737–772. 4 indexed citations

Hung, Daniel Y., et al.. (2005). Hepatic pharmacokinetics of taurocholate in the normal and cholestatic rat liver. British Journal of Pharmacology. 145(1). 57–65. 22 indexed citations

Hung, Daniel Y., G. Siebert, M. W. Whitehouse, et al.. (2005). Hepatic pharmacokinetics of propranolol in rats with adjuvant-induced systemic inflammation. American Journal of Physiology-Gastrointestinal and Liver Physiology. 290(2). G343–G351. 21 indexed citations

Hung, Daniel Y., et al.. (2005). Therapeutic Effects and Possible Mechanisms of a Snake Venom Preparation in the Fibrotic Rat Liver. Digestive Diseases and Sciences. 50(4). 745–752. 3 indexed citations

Hung, Daniel Y., et al.. (2004). Disposition Kinetics of Propranolol Isomers in the Perfused Rat Liver. Journal of Pharmacology and Experimental Therapeutics. 311(2). 822–829. 9 indexed citations

Siebert, G., et al.. (2004). Ion-Trapping, Microsomal Binding, and Unbound Drug Distribution in the Hepatic Retention of Basic Drugs. Journal of Pharmacology and Experimental Therapeutics. 308(1). 228–235. 58 indexed citations

10.

Hung, Daniel Y., et al.. (2004). Reduced hepatic extraction of palmitate in steatosis correlated to lower level of liver fatty acid binding protein. American Journal of Physiology-Gastrointestinal and Liver Physiology. 288(1). G93–G100. 10 indexed citations

11.

Hung, Daniel Y., Frank J. Burczynski, Andrew L. Lewis, et al.. (2003). Fatty acid binding protein is a major determinant of hepatic pharmacokinetics of palmitate and its metabolites. American Journal of Physiology-Gastrointestinal and Liver Physiology. 284(3). G423–G433. 15 indexed citations

12.

Hung, Daniel Y., et al.. (2002). Quantitative evaluation of altered hepatic spaces and membrane transport in fibrotic rat liver. Hepatology. 36(5). 1180–1189. 20 indexed citations

13.

Hung, Daniel Y., et al.. (2002). Cationic Drug Pharmacokinetics in Diseased Livers Determined by Fibrosis Index, Hepatic Protein Content, Microsomal Activity, and Nature of Drug. Journal of Pharmacology and Experimental Therapeutics. 301(3). 1079–1087. 51 indexed citations

14.

Weiss, Michael A., Olaf Kuhlmann, Daniel Y. Hung, & Michael S. Roberts. (2000). Cytoplasmic binding and disposition kinetics of diclofenac in the isolated perfused rat liver. British Journal of Pharmacology. 130(6). 1331–1338. 24 indexed citations

15.

Pinkerton, Kent E., Francis H. Y. Green, Cathy Saiki, et al.. (2000). Distribution of Particulate Matter and Tissue Remodeling in the Human Lung. Environmental Health Perspectives. 108(11). 1063–1063. 14 indexed citations

16.

Hung, Daniel Y., George D. Mellick, Paul P. Masci, et al.. (1998). Focused antithrombotic therapy: Novel anti-platelet salicylates with reduced ulcerogenic potential and higher first-pass detoxification than aspirin in rats. Journal of Laboratory and Clinical Medicine. 132(6). 469–477. 6 indexed citations

17.

Hung, Daniel Y., George D. Mellick, Yuri G. Anissimov, Michael Weiß, & Michael S. Roberts. (1998). Hepatic structure‐pharmacokinetic relationships: The hepatic disposition and metabolite kinetics of a homologous series of O‐acyl derivatives of salicylic acid. British Journal of Pharmacology. 124(7). 1475–1483. 14 indexed citations

18.

Hung, Daniel Y., et al.. (1998). The Effect of Protein Binding on the Hepatic First Pass of O-Acyl Salicylate Derivatives in the Rat. Journal of Pharmacy and Pharmacology. 50(1). 63–69. 6 indexed citations

19.

Hung, Daniel Y., George D. Mellick, Yuri G. Anissimov, Michael A. Weiss, & Michael S. Roberts. (1998). Hepatic Disposition and Metabolite Kinetics of a Homologous Series of Diflunisal Esters. Journal of Pharmaceutical Sciences. 87(8). 943–951. 12 indexed citations

20.

Hung, Daniel Y., George D. Mellick, Richard J. Prankerd, & Michael S. Roberts. (1997). Synthesis, identification, characterization, stability, solubility, and protein binding of ester derivatives of salicylic acid and diflunisal. International Journal of Pharmaceutics. 153(1). 25–39. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact